



The past few decades have seen glaucoma research 
undergo significant advances, particularly in the areas of 
pathophysiology and investigative techniques. While new 
sophisticated methods of imaging the retina and optic nerve 
and measuring intraocular pressure have become available of 
late, many clinicians still find themselves using the same tests 
for measuring the visual field that have been used in previous 
generations. What real advancements have been made in 
recent years and where is perimetry going? 
A brief history
Perimetry is the quantitative evaluation of the visual field 
and has been a subject of interest to philosophers, scientists 
and clinicians for over 2500 years. Although the visual field 
was being measured by various scientists, such as da Vinci, 
Young and Purkinje, the introduction of visual field testing in 
medical practice is attributed to Von Graefe. Von Graefe used 
a flat wire grid, similar to that previously used by Helmholtz 
to direct a patient’s fixation during fundoscopy, in order to 
map scotomata in his patients. Scientists soon began to 
recognise the importance of maintaining a constant distance 
between the test object and the eye, and so arc perimetry 
was introduced. In 1889, Bjerrum introduced a method for 
examining for defects in the central visual field in a short note 
entitled An addendum to the usual examination of the visual 
field of glaucoma, and first described his finding of an arcuate 
scotoma at approximately 15° retinal eccentricity in people 
with glaucoma. This technique involved the movement of 
circular discs of different sizes (attached to a wand) from the 
periphery to the centre of a black cloth screen (ie from areas of 
non-seeing to seeing) – a perimeter now commonly known as 
a Bjerrum tangent screen. 
Goldmann introduced his eponymous bowl perimeter in 
1945, which employed much the same principle, with the 
added benefits of better defect quantification and a shorter 
working distance than the Bjerrum screen, allowing a greater 
extent of the field to be measured. Goldmann standardised 
test conditions such as background luminance and stimulus 
luminance and introduced the popular Goldmann stimulus 
sizes (0–V). 
In 1959, Harms & Aulhorn employed static stimuli on a bowl 
perimeter (the Tübingen perimeter), allowing more precise 
quantification of the sensitivity of the visual field at precise 
locations and hence more accurate grading and monitoring of 
disease. This was the forerunner of standard static automated 
perimetry (SAP) that is used in many ophthalmic clinics 
worldwide today. Threshold-related screening techniques were 
developed and evaluated alongside thresholding techniques 
as methods of rapid and efficient disease detection (Drance 
et al. 1972; Harrington & Flocks 1954). The 1980s saw the 
evolution of automated perimetry as well as various methods 
incorporating novel types of stimulus, following ever-updated 
reports on glaucomatous pathophysiology and proposals 
of selective loss of specific cell types. Today, many different 
screening and thresholding techniques exist.
Why measure the visual field?
Measurement of the visual field is of great importance in the 
investigation of many conditions affecting the visual pathway, 
including retinal lesions, compressive lesions and vascular 
accidents. It is also well understood that, for evaluation of some 
conditions, the extent of the visual field is of most importance, 
while for other conditions, the depth of the defect is equally as 
important. Perhaps the most common reasons for performing 
perimetry are the detection, evaluation and monitoring of 
glaucoma. Visual field defects in glaucoma can influence 
hand–eye coordination (Kotecha et al. 2009), increase the 
probability of falling (Haymes et al. 2007) and, perhaps 
crucially, increase the risk of causing or being involved in a motor 
vehicle accident (Haymes et al. 2007; McGwin et al. 2005). 
As such, knowledge of the extent and depth of visual 
disability in the presence of glaucoma, and any progression 
thereof, is essential. Although many of the basic principles, 
methods, standards and much of the instrumentation 
employed in perimetry have remained largely unchanged 
over the past few decades, significant progress in perimetric 
research of late has led to improved accuracy and precision in 
glaucoma diagnosis and monitoring. However, new innovations, 
including those in perimetric research, are often slow to reach 
the ophthalmic clinic and the optometrists’ practice. One study 
has revealed that it takes 17 years (on average) for research 
findings to be translated from a laboratory setting to a clinical 
setting (Balas & Boren 2000). 
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plotted on a common scale, considerable variability exists 
(Figure 2). Swanson et al. (2004) and Pan & Swanson (2006) 
provided even more food for thought. Importantly, they 
point out that one obvious and very notable oversight in the 
relationship between retinal structure and visual function is 
the influence of higher-level cortical processing on the 
perimetric stimulus. The majority of published clinical 
research on the structure/function relationship in glaucoma 
has concentrated on the relationship between visual field 
sensitivity and retinal structure (Garway-Heath et al. 2002; 
Harwerth et al. 1999; Hood & Kardon 2007; Quigley et al. 
1982). Although these studies provide reasonable suggestions 
for sources of discrepancy between these parameters, 
the effect of higher-level cortical processing has received 
disproportionately little attention. It is convenient to assume 
that the rate of visual field loss is equal to the rate of retinal 
ganglion cell loss in glaucoma. However, consideration of 
the many levels of stimulus processing higher up in the 
visual system (eg in the visual cortex), as well as the scale 
on which measurements are plotted, may render such an 
assumption simplistic. Swanson et al. (2004) proposed a 
two-stage relationship between perimetric sensitivity 
(measured with a Humphrey field analyzer) and underlying 
ganglion cell density in the healthy eye, accounting both 
for differences in ganglion cell density at different retinal 
eccentricities as well as differences in cortical processing for 
those eccentricities. 
Figure 2. The structure/function relationship is linear when 
data are plotted on linear axes. Adapted from Garway-Heath 
et al. (2002).
While the structure/function relationship has interested 
scientists and clinicians for many years, consideration of 
higher-level processing depends on whether one wishes 
to know the relationship between ganglion cell loss and 
the resulting drop in visual field sensitivity, or how results 
of a functional test relate to those of a structural test 
in a between-test comparison. Reports of significant 
retinal ganglion cell loss prior to detection of glaucoma by 
conventional static perimetry, along with reports of high 
measurement variability (Artes et al. 2005; Wall et al. 2009), 
particularly in regions of reduced sensitivity, have gained 
This article will discuss recent attempts to identify more 
precisely the mechanisms by which the visual system responds 
to conventional perimetric stimuli, with a view to improving the 
diagnostic accuracy and clinical meaning of results from SAP. 
A comprehensive indepth report of all recent research findings 
is beyond the scope of the current article; however previously 
published reports will be indicated where appropriate.
Perimetry in glaucoma –  
where are we now?
Glaucoma is characterised by a loss of retinal ganglion cells 
(Quigley et al. 1982) and this loss can be detected clinically by 
measuring either retinal structure or visual function. 
Visual field testing remains the primary functional biomarker 
for the presence of glaucoma and its progression. The ideal 
perimetric test for glaucoma is one that is highly sensitive 
and specific to the condition, reproducible, quick and 
patient-friendly. Currently, no perimetric test exists that 
meets all of these criteria simultaneously. It is often reported 
by clinicians and researchers that significant ganglion cell loss 
(up to 50%) can occur before SAP can adequately detect 
functional loss. These notions come from the findings of 
studies such as those of Quigley et al. (1982) and Harwerth 
et al. (1999). However, the former study suffered considerably 
from a low sample size, and the latter from the log-linear 
scale used to present the data graphically, ie when a log value 
(sensitivity loss in decibels) was plotted against a linear value, 
larger, later losses of ganglion cells were emphasised, and 
smaller, earlier losses less so (Figure 1).
Figure 1. The relationship between sensitivity loss and 
ganglion cell loss in the macaque eye. Adapted from 
Harwerth et al. (1999).
A later paper by Garway-Heath et al. (2002), employing 
temporal rim area, measured with a Heidelberg retina 
tomograph (HRT: Heidelberg Engineering, Heidelberg, 
Germany), as the structural measure showed that, when 
structure and function are both plotted on a common scale, 
the association between them becomes linear. One striking 
feature of the data of Garway-Heath et al. (2002) is that, 
although structure and function can be linearly associated when 
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widespread attention and have subsequently catalysed 
the development of more objective tests for measuring 
structures such as optic disc neuroretinal rim area, eg HRT, and 
retinal nerve fibre thickness, eg GDx (Carl Zeiss Meditec, 
Dublin, CA) or optical coherence tomography (OCT). While 
imaging technology such as OCT has certainly made a valuable 
contribution to the detection of disease and its progression 
in optometric practice, it must be borne in mind that such 
objective tests merely allow surrogate measures of ganglion 
cell axon density and, perhaps more importantly, do not 
measure what we are ultimately trying to preserve, namely 
ganglion cell function. For similar reasons as those described 
above, various alternative forms of perimetry have been 
investigated, such as frequency-doubling technology (FDT) 
(Johnson & Samuels 1997), short-wavelength automated 
perimetry (SWAP) (Johnson et al. 1993; Sample & Weinreb 
1990), high-pass resolution perimetry (Frisen 1987) and motion 
perimetry (Verdon-Roe et al. 2006; Wall et al. 2009). While a 
large body of research continues to focus on such alternative 
perimetric methods for characterising visual sensitivity, 
other significant areas of perimetric research include the 
investigation of ways in which noise, from either measurement 
or analysis, can be overcome, in order to improve the disease 
‘signal’, ie improve the ability of tests to report the definite 
presence or progression of glaucoma (Artes & Chauhan 
2009; Chauhan et al. 2008; Turpin et al. 2007). In addition, 
methods for improving clinical interpretation of results of 
existing test modalities (Bengtsson et al. 2009; Viswanathan 
et al. 1997) and screening methods such as suprathreshold 
perimetry (Artes et al. 2003; Henson & Artes 2002) have been 
developed. Recent interest has also been directed towards the 
appropriate frequency of visual field testing to detect 
progression (Crabb & Garway-Heath 2009; Heijl et al. 2008) 
and the ways in which existing test stimuli can be altered in 
order to make results more repeatable (Redmond et al. 2010; 
Wall et al. 2009). 
To date, prediction of visual field defects from structural 
measures remains poor (Zhu et al. 2010) and we are not 
currently in a position to replace measurements of visual 
function with measurements of retinal structure or vice versa. 
It is widely accepted by clinicians and scientists alike that 
consideration of results from functional and structural tests in 
combination affords greater power to clinical decision-making.
 
Why are we still using standard 
automated perimetry?
It is reasonable to ask why the visual field is measured using 
scenes that do not mimic real-world tasks. Currently, the 
gold-standard method for measuring the visual field is to 
record the ability to detect small, brief, white circular stimuli 
on a white background. This is hardly a visual task that 
is performed during a normal everyday schedule. It may 
therefore be argued that tests of visual function that are more 
representative of real-world tasks (eg the presentation of 
stimuli on natural images) should instead be used to measure 
simultaneously the impact of glaucoma on everyday seeing 
and quality of life. Additionally, some may argue that current 
methods of measuring the visual field are rudimentary and 
outdated. While this might appear to be the case, it can also 
be argued that the test has the advantage of being a widely 
understood perimetric test. Almost all of our understanding of 
visual field progression in glaucoma comes from clinical trials 
and other studies that have used only standard automated 
perimetry to define the visual field. Furthermore, the test is a 
stable technology, very familiar to clinicians in most hospital 
glaucoma clinics and optometric practices, and many clinicians 
may have reservations about switching from one perimeter to 
another while in the process of carefully monitoring a patient 
for the presence of glaucoma or its progression. It is reasonable 
to propose that, for effective monitoring of glaucoma, frequent, 
stable tests are required, regardless of whether they are new 
or old. Despite many years of developing newer perimetric 
tests, as well as clinical structural tests, SAP has stubbornly 
remained the gold standard for the detection and monitoring 
of glaucoma and, as such, it is important that one understands 
fully the results that it reports, even though these results are 
often subject to considerable variability. 
It might reasonably be argued that the better use of existing 
perimetric tests (including appropriate frequency of testing) 
and better analysis of their results can build on our clinical 
understanding of the way in which patients are affected 
visually in glaucoma, as well as help us identify glaucoma in its 
earliest stages or the smallest signs of progression. To do this, 
it is worth considering the fundamentals of detection of a spot 
stimulus and how the ability of the visual system to process the 
stimulus changes as the disease progresses. Currently, SAP can 
be performed using a range of stimulus sizes (Goldmann sizes), 
while the duration of the stimulus on the screen is generally 
fixed at 0.2 seconds. Stimuli are varied in brightness according 
to the response of the patient, until threshold contrast is 
reached. This is translated into a clinically meaningful visual 
field sensitivity value. Fundamentally, in SAP, one is measuring 
the lowest number of photons eliciting a response in the visual 
pathway for a fixed stimulus size. However, the number of 
photons delivered to the retina can be altered in various ways. 
For example, instead of increasing the number of photons by 
increasing stimulus contrast, one could increase the area of the 
stimulus, while keeping the contrast constant. Likewise, one 
could fix the area and contrast of the stimulus and increase 
its duration. As a consequence, three potential variables 
warrant consideration: stimulus contrast, area and duration. 
Varying contrast, area and duration (either in isolation or 
simultaneously) may well have different degrees of success in 
the detection and monitoring of glaucoma. Anderson (2006) 
reminded us that Goldmann stimuli were introduced to SAP 
from kinetic bowl perimetry, as were the stimulus duration of 
0.2 seconds and the background luminance of 10cd/m2, and 
that as long as there is standardisation of methods in SAP, it 
is not essential that these parameters are fixed at the levels 
recommended for kinetic perimetry. Careful consideration of 
the way in which these parameters should be altered suggests 
that a considerable amount of the variability and reduced 
diagnostic accuracy of conventional SAP may be explained 
by the inappropriate importation of fixed parameters from a 
different perimetry type.
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Spatial summation: basic principles and 
relevance to perimetry
‘Summation’ is the term given to the way in which the visual 
system adds up the light energy within a stimulus. ‘Spatial 
summation’ is the ability of the visual system to add up light 
energy across a given stimulus area. It is a phenomenon that 
was investigated at great length by scientists in the latter half 
of the 19th century and throughout the 20th century and 
is highly relevant to perimetry. Only in the past 20 years or 
so has interest in spatial summation made a revival in 
perimetric literature. The retina absorbs the photon light 
energy that reaches it from a visual stimulus. Threshold is 
reached when the stimulus contains enough energy overall to 
overcome visual noise and elicit a visual response. For a range 
of small stimuli the effect of changing either size or intensity 
is proportionally the same, such that reducing the intensity of 
a stimulus at threshold by 50% means that the stimulus must 
be twice as large in order to reach threshold again, ie stimulus 
area (A) and stimulus intensity (I) are inversely proportional: 
I × A = k, and the slope of the line joining threshold values for 
these stimuli is –1 (Figure 3). This relationship is commonly 
referred to as Ricco’s law and describes complete spatial 
summation. However, this relationship breaks down for 
larger stimuli and summation is said to be incomplete, in 
that a twofold decrease in stimulus intensity is no longer 
compensated for by a doubling of the stimulus area. On 
the spatial summation curve (Figure 3), the slope of the line 
joining thresholds for these larger stimuli is between 0 and 
–1, depending on testing conditions. At what point does 
complete summation break down? The largest stimulus size 
for which complete summation still applies is known as the 
critical summation area or Ricco’s area (the kink in the curve 
in Figure 3). 
The exact physiological basis for this limit to complete spatial 
summation has been a topic of great debate for many decades, 
but it has traditionally been thought to represent the size of 
the centre mechanism of centre/surround receptive fields 
(Figure 3) of retinal ganglion cells (Glezer 1965). However, 
more recent studies have suggested that the size of Ricco’s area 
is influenced by the extent of receptive fields of cortical cells 
(Pan & Swanson 2006; Swanson et al. 2004). Regardless of the 
exact underlying physiology, measured sensitivity depends on 
whether the stimulus is small enough to undergo complete 
summation or if it is sufficiently large that it will undergo 
incomplete summation. Thus, the way in which perimetric 
sensitivity levels change in response to ganglion cell loss is 
determined by whether the stimulus size is larger or smaller 
than Ricco’s area (Anderson 2006). Ricco’s area is not a fixed 
parameter. It is larger in the retinal periphery (Volbrecht et al. 
2000; Wilson 1970), larger under lower levels of background 
luminance (Barlow 1958; Glezer 1965) and larger for stimuli 
of shorter duration (Hood & Finkelstein 1986). Ricco’s area 
also differs for stimuli of different wavelength (Brindley 1954; 
Volbrecht et al. 2000) and therefore influences the way in 
which sensitivity values for standard white-on-white perimetry 
and short-wavelength perimetry should be compared.
Figure 3. Schematic of a typical white-on-white spatial 
summation curve. A slope of –1 indicates an inverse 
relationship between area and intensity at threshold (Ricco’s 
law applies). For stimuli larger than Ricco’s area (denoted by 
solid arrow), this relationship no longer holds. Data points 
are larger for larger stimuli, to aid interpretation. The size 
of a Goldmann III stimulus is denoted by the dashed arrow. 
Centre/surround receptive fields are shown on top, showing 
the relative size of the stimulus and the receptive field. It is 
thought that Ricco’s area is the stimulus size that equates 
to the size of a receptive field centre and that Ricco’s law 
breaks down once the stimulus is larger than the receptive 
field centre. 
Considering spatial summation in the context of clinical 
perimetry, the size of Ricco’s area for white stimuli on a 
white background is very small, although it does enlarge 
with retinal eccentricity (Wilson 1970). By contrast, the size 
of the stimulus employed in SAP (the Goldmann III) remains 
constant. Therefore, one might expect that Ricco’s area may 
be larger or smaller than the Goldmann III stimulus at different 
regions of the retina. Indeed, Ricco’s area is much smaller 
than the Goldmann III stimulus for most of the central retina. 
At approximately 15° retinal eccentricity however, Ricco’s area 
is approximately equal in size to a Goldmann III stimulus and is 
larger than it is at regions beyond 15°. This means that, within 
15° in the normal eye, threshold is determined by incomplete 
spatial summation, whereas beyond 15°, it is determined by 
complete spatial summation. Interestingly, Wilson (1970) 
found that, while Ricco’s area enlarges with greater eccentricity 
from the fovea, sensitivity for Ricco’s area-sized stimuli 
remains constant. Put simply, this is evidence for a scaling 
factor with eccentricity (rather like a cortical magnification 
factor) that is probably regulated by cortical receptive fields. 
The relationship between retinal structure and visual function 
described by Swanson et al. (2004) for the healthy retina takes 
these findings into account (Figure 4). 
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Figure 4. The two-stage structure/function model of 
Swanson et al. (2004). Adapted from Swanson et al. (2004). 
These authors calculated that, beyond 15° retinal eccentricity, 
where the stimulus is smaller than Ricco’s area, sensitivity 
declines by 1 log unit (ie 10dB) for each log unit reduction 
in ganglion cell number (dB = 10 × log(x)). However, within 
15°, where the stimulus is larger than Ricco’s area, sensitivity 
declines by 0.25 log units (ie 2.5dB) for each log unit decrease 
in ganglion cell number. So, the relative size of the stimulus and 
Ricco’s area determines the normal sensitivity level for a given 
ganglion cell density. 
Ricco’s area in glaucoma
Fellman et al. (1989) carried out a series of experiments 
investigating spatial summation in glaucoma and made several 
observations. They found that the difference in threshold 
between Goldmann III and V stimuli was greater in glaucoma 
patients than in healthy controls. They also demonstrated 
that, in attempting to improve visibility of the stimulus, 
increasing the area of the stimulus had a greater effect in 
glaucoma patients than increasing contrast. In normals, they 
found the opposite to be the case. The authors concluded that 
the increased sensitivity to larger stimuli in glaucoma could 
be due to either the stimulus covering more normal retinal 
areas that surround the defective region or pathological spatial 
summation whereby light is absorbed over a larger area than 
would be expected in the normal eye. Ricco’s area has recently 
been shown to enlarge in glaucoma (Redmond et al. 2010) 
(Figure 5). Interestingly, the spatial summation curve undergoes 
a direct rightward shift in glaucoma, with no vertical shift, and 
the sensitivity at Ricco’s area is the same between patients and 
healthy controls.
When changes in Ricco’s area are accounted for, ie when 
the glaucoma curve is displaced back along the x-axis by an 
amount equal in size to the change in Ricco’s area, sensitivity 
for glaucoma patients and healthy subjects is equivalent, 
indicating that changes in Ricco’s area can account for most, 
if not all, of the sensitivity loss found in early glaucoma using 
conventional Goldmann III stimuli (see Figure 5 in Redmond 
et al. (2010)). Such a finding suggests an adaptive mechanism 
in the visual cortex to preserve visual sensitivity in response 
to ganglion cell loss. If one assumes that Ricco’s area is related 
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Figure 5. Spatial summation curves for (a) white-on-white 
stimuli and (b) blue-on-yellow stimuli. Curves are shown 
for the superior visual field only. Dotted lines indicate the 
size of Ricco’s area in each case. Adapted from Redmond 
et al. (2010). 
Ricco’s area suggests that, when ganglion cells die, cortical 
cells to which the dead ganglion cells once projected receive 
extra input from remaining ganglion cells adjacent to those 
that have died, ie greater convergence of ganglion cells on to 
cortical cells. This finding is similar to that of Wilson (1970), of 
an enlargement of Ricco’s area with eccentricity in the normal 
eye, and indicates that the structure/function relationship 
found by Swanson et al. (2004) may also be applied to the 
glaucomatous eye. Clinically, the finding of an enlarged Ricco’s 
area in glaucoma means that the size of the stimulus employed 
in perimetry should be compared to the size of Ricco’s area 
for that stage of the disease in order to calculate the rate of 
sensitivity loss per unit ganglion cell loss. When Ricco’s area 
is smaller than the Goldmann III stimulus, sensitivity should 
decline at a rate of 2.5dB per log unit decline in ganglion cell 
density (incomplete summation). When Ricco’s area enlarges 
beyond the size of a Goldmann III stimulus, sensitivity should 
decline thereafter at a rate of 10dB per log unit decline in 
ganglion cell density (complete summation). Swanson et al. 
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(2004) estimated the SAP sensitivity for a stimulus of equal 
size to Ricco’s area to be constant at 31.25dB, regardless of 
the region of retina being tested. This means that summation 
switches from incomplete to complete at 31.25dB. In other 
words, a 1dB reduction in sensitivity above 31.25dB indicates 
a reduction of ganglion cell density of 0.4 log units whereas 
a 1dB reduction in sensitivity below 31.25dB suggests a 
ganglion cell reduction of only 0.1 log units. It is important to 
note that sensitivity values reported by Swanson et al. (2004) 
were specific to the Humphrey Field Analyzer I (Carl Zeiss 
Meditec, Dublin, CA). Researchers and clinicians often consider 
the rate at which SAP sensitivity declines. It is well known 
among clinicians that SAP sensitivity is highly variable, with 
variability increasing as visual loss increases. It is reasonable 
to suggest that, in the early stages of disease, where the rate 
of SAP sensitivity loss is shallow compared to the loss of 
ganglion cells, subtle sensitivity loss, in the presence of high 
measurement variability, is detected with greater confidence 
once Ricco’s area becomes larger than the stimulus.
Exploiting changes in Ricco’s  
area in glaucoma
How could we use information about the changing nature of 
Ricco’s area in glaucoma to improve clinical testing? Why don’t 
we simply perform SAP with a stimulus that is always smaller 
than Ricco’s area? This suggestion is valid; however it is also 
known that in SAP, where the varying parameter is contrast, 
sensitivity measurements are more variable for smaller stimuli 
than for larger stimuli (Gilpin et al. 1990). Plotting a patient’s 
spatial summation curve would require the patient to undertake 
multiple visual field tests using differently sized stimuli, and in 
a busy optometric practice or hospital clinic this is not feasible. 
Estimating the degree of enlargement of Ricco’s area from 
conventional stimuli varying in contrast is challenging and 
can often be inaccurate. Anderson (2006) and Redmond et 
al. (2010) suggest an alternative approach whereby stimulus 
area is varied either instead of intensity (stimuli varying 
along the x-axis in Figures 3 and 5), or simultaneously with 
it (stimuli varying diagonally at 45° in Figures 3 and 5) after 
each patient response. A stimulus varying in area, with a 
starting value smaller than Ricco’s area, would offer the 
potential to measure directly the lateral displacement of the 
spatial summation curve in each patient and improve the 
ability of the test to report definite presence or progression 
of glaucoma at the same time. Furthermore, this modification 
to SAP may readily be applied to current instrumentation 
without changing the task or experience of the patient. If the 
contrast and size of the stimulus are arranged such that the 
stimulus always undergoes complete spatial summation (ie if 
the size of the stimulus is always smaller than Ricco’s area), 
then the rate of sensitivity loss will always be expected to be 
1 log unit for every log unit decline in ganglion cell density. 
The importance of altering stimulus size in perimetry has also 
been acknowledged in other contemporary works (Johnson et 
al. 2010; Wall et al. 2009).
Other changing perspectives in perimetry
Recent years have witnessed a revolution of ideas in clinical 
perimetry. While some newer perimetric tests have been 
welcomed in clinical practice, other promising tests of 
visual function in glaucoma have been almost completely 
abandoned in the clinical setting. SWAP was first introduced 
in the early 1990s and early investigations into the usefulness 
of the technique in measuring glaucomatous loss suggested 
that sensitivity to blue stimuli on a yellow background 
was reduced before sensitivity loss for conventional 
white-on-white stimuli could be detected (Johnson et 
al. 1993; Sample & Weinreb 1990). One study suggested 
that sensitivity loss in glaucoma could be predicted by SWAP 
up to 3–5 years before being detected by SAP (Johnson et 
al. 1993). More recent investigations in this area have revealed 
that SAP identifies almost as many patients with early 
glaucoma as SWAP (Bengtsson & Heijl 2006), with one study 
even reporting that sensitivity loss could be detected by SAP 
before it could be detected by SWAP (van der Schoot et al. 
2009). In consideration of changes in spatial summation in 
glaucoma, Redmond et al. (2010) found that Ricco’s area for 
blue-on-yellow stimuli also enlarged in glaucoma, but 
by a lesser amount than that for white-on-white stimuli 
(Figure 5b). Furthermore, the relative difference in size 
between Ricco’s area for blue-on-yellow stimuli and the 
Goldmann V stimulus used in SWAP is greater than that 
between Ricco’s area for white-on-white stimuli and the 
Goldmann III stimulus. This suggests that the white-on-white 
Ricco’s area would be expected to become larger than 
the Goldmann III before the chromatic Ricco’s area 
becomes larger than the Goldmann V. Thus, for the same 
stage of disease, the rate of visual loss for a given rate 
of ganglion cell loss would be expected to be greater for 
white-on-white perimetry.
It has often been proposed that the magnocellular pathway 
is affected before the parvocellular pathway in glaucoma. 
The magnocellular pathway demonstrates greater sensitivity 
to rapidly moving (or flickering) achromatic stimuli and 
low spatial frequencies while the parvocellular pathway 
demonstrates greater colour contrast and greater sensitivity 
to static stimuli and high spatial frequencies. However, these 
two cell types display notable functional overlap (Merigan 
& Maunsell 1993; Pokorny & Smith 1997). Initial reports of 
selective damage to ganglion cells with larger axons and cell 
bodies (Quigley et al. 1988) were thought to demonstrate 
selective damage to the magnocellular pathway (Dandona et 
al. 1991). Thus, tests that purported to test the magnocellular 
pathway selectively in glaucoma (eg FDT) were devised 
(Johnson & Samuels 1997). Later studies do not support the 
notion of selective magnocellular loss (Morgan 2002). In fact, 
it has been proposed that what Quigley et al. (1988) probably 
observed during their experiments was an overall shrinkage of 
ganglion cells in early glaucoma, rather than a selective loss 
of larger neurons (Morgan 2002). While it has traditionally 
been thought that tests such as FDT target predominantly 
the magnocellular pathway and that stimuli employed in SAP 
target predominantly the parvocellular pathway, it should 
be noted that it is very likely that these tests elicit responses 
from both of these pathways as well as many other pathways 
mediated by other cell types. Recent convincing evidence 
points towards SAP stimuli actually eliciting a greater response 
from the magnocellular pathway than the parvocellular 
pathway (Swanson et al. 2010). Chauhan et al. (2008) 
recommend that, although newer tests such as FDT and SWAP
Visual Fields: Back to the Future
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may help to confirm visual field loss in glaucoma, they should 
be considered as supplementary tests to SAP and should not 
be carried out as a substitute for it.
Frequency of testing
Although many studies deliberate the effectiveness of various 
tests at detecting glaucoma in the first instance as well as 
monitoring progression, it should also be borne in mind that 
frequency of testing has a sizeable influence in this regard. It 
is well accepted that notable variability accompanies visual 
field sensitivity measurements and the amount of variability 
can differ between patients and between normal and affected 
regions of the field. Confirmation of the presence of glaucoma 
or its progression can be hindered by high levels of measurement 
variability, resulting from fixation instability, learning effects, 
liberal response characteristics, understanding and instrument 
variability. Many optometrists and other eyecare professionals 
are familiar with the scenario where a repeated visual field test 
appears very different from the baseline, even when both tests 
are performed on the same day. Sometimes the subsequent 
test can reveal higher sensitivity while at other times it can 
reveal lower sensitivity. Often the clinician will then perform 
a third visual field test and consider all three in combination. 
The goal to interpreting visual field plots successfully over time 
therefore is to overcome measurement variability as best as 
one can at each test. Generally, for a patient who has glaucoma 
that is progressing, a greater frequency of testing is more likely 
to reveal visual field changes above variability. Currently, the 
National Institute for Health and Clinical Excellence (NICE) 
recommends performing a visual field test every 6–24 
months, depending on whether the target intraocular pressure 
is met as well as the risk of the patient developing chronic 
open-angle glaucoma. 
Chauhan et al. (2008) have provided useful recommendations 
for the frequency of testing in order to detect different rates 
of progression of visual field loss in patients with low, 
moderate and high levels of measurement variability, based 
on visual field data collected from patients over several years 
(Artes & Chauhan 2005). They report that, in order to be 80% 
confident of detecting rapid visual field loss (defined as –2dB 
mean deviation per year) among moderate variability over 
the space of 2 years, one must perform three visual field tests 
per year. However, very often patients’ responses are highly 
variable and if progression is slow (eg when the patient is taking 
topical medication for glaucoma), the recommended frequency 
of testing increases. For example, if visual fields are measured 
once per year on a patient with moderate variability, it will 
take approximately 13 years to be 80% confident of moderate 
visual field progression (defined as –0.5dB mean deviation 
per year). If the frequency of testing is increased to twice per 
year, this timescale is reduced to 6.5 years and if three tests 
are performed in the year, the timescale is reduced further to 
4.3 years. In a busy optometric practice or hospital clinic, 
however, it is often unrealistic to carry out a large number of 
visual field tests on each glaucoma patient or glaucoma suspect. 
A recent study by Crabb & Garway-Heath (2009) simulated 
visual fields and suggested that greater confidence of the 
presence of progression could be achieved by using a ‘wait and 
see’ approach. Using the example of Chauhan et al. (2008) 
above, Crabb & Garway-Heath suggest that performing 
three visual field tests at the beginning of the 2-year period 
and three tests at the end of the 2-year period allows 
for better estimates of rate of loss and leads to better 
discrimination between progression and stability. The 
investigators recommend however that other tests for 
glaucoma progression be carried out in the meantime, with 
normal clinical intervention if appropriate (D P Crabb, personal 
communication, May 2009).
Conclusions
The assessment of visual function in glaucoma is crucial for 
the understanding of a patient’s stage of disease as well as 
his or her possible visual disability. Despite reports of reduced 
sensitivity of standard automated perimetry to detect 
glaucoma presence or progression, this form of perimetry is 
currently that which is most widely studied and recognised 
by clinicians. Standard automated perimetry has imported 
many of the standard fixed parameters used in Goldmann 
kinetic perimetry and it is reasonable to suggest that a return 
to first principles and a redesign of currently employed stimuli 
(particularly varying the area of the stimulus) may afford the 
test increased diagnostic accuracy in a clinical setting.
 Summary
This article provides an overview of recent research in 
perimetry as well as some emerging ideas for improving 
the ability of perimetric testing to detect glaucoma 
and its progression. It discusses the benefits of carrying 
out perimetric tests as part of the evaluation and 
management of patients with glaucoma and those 
suspected of having the condition, arguing that stable 
technology is necessary for continued monitoring. The 
frequency with which a visual field should be carried 
out in order to detect glaucoma or its progression is 
also discussed.
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Multiple choice questions
This paper is reference C-15697. Three points are available 
for optometrists. Please use the inserted answer sheet. Copies 
can be obtained from Optometry in Practice Administration, 
PO Box 6, Skelmersdale, Lancashire WN8 9FW. There is only 
one correct answer for each question. 
1.  Who is generally accredited for first describing an arcuate 











3.  Regarding visual field loss, which of the following 
statements is incorrect?
(a) Both the extent and depth of fields loss are important
(b)  There is no evidence that glaucomatous visual field 
loss can increase the risk of being involved in a motor 
vehicle accident
(c) Visual field loss can influence hand–eye coordination
(d) Visual field loss can increase the probability of falling
4.  According to Balas & Boren (2000), how long does it take, 
on average, for research findings to reach a clinical setting 















7.  Which of the following is not a method of altering the 
number of photons reaching the retina during a SAP 
stimulus presentation?
(a) Increasing stimulus area
(b) Decreasing stimulus contrast
(c) Decreasing stimulus duration
(d) Increasing the time between presentations
8. Which of the following describes Ricco’s law?
(a) Area × Intensity = –k
(b) Duration/Intensity = k
(c) Area × Intensity = k
(d) Duration × Intensity = –k 
9.  At what retinal eccentricity is Ricco’s area for a 
white-on-white stimulus approximately equal to the size of 
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10.  According to the structure/function relationship described 
by Swanson et al. (2004), how much does sensitivity 
decline for a log unit reduction in ganglion cell density for 





11. Which of the following statements is true?
(a) Ricco’s area is the same size at all retinal eccentricities
(b) Ricco’s area enlarges in glaucoma
(c)  Spatial summation describes the amount of light that 
passes through the cornea and lens
(d)  The optical quality of the eye forms the physiological basis 
for Ricco’s area
12. Which of the following is not true?
(a)  A reduction in sensitivity of 2.5dB per log unit reduction 
in ganglion cell density is a consequence of incomplete 
summation
(b) Ricco’s area differs for stimuli of different wavelength
(c) SAP is the gold-standard test for visual function in glaucoma
(d)  Sensitivity measurements are more variable for larger 
stimuli
13.  According to the structure/function relationship described 
by Swanson, below what sensitivity is threshold for the SAP 





14.  To which of the following stimuli is the magnocellular 
pathway more sensitive than the parvocellular pathway?
(a) Coloured stimuli
(b) Flicker stimuli
(c) Stimuli containing high spatial frequencies
(d) Circular stimuli
15.  According to Chauhan et al. (2008), how many years 
might it take to be 80% confident of moderate visual field 
progression with moderate variability if two visual field 






After reading this article can you identify areas in which 
your knowledge of perimetry has been enhanced?
How do you feel you can use this knowledge to offer 
better patient advice?
Are there any areas you still feel you need to study and 
how might you do this?
Which areas outlined in this article would you benefit 
from reading in more depth, and why?
